文献速递消化内镜消化道肿瘤与早癌

分块冷圈套息肉切除术与传统内镜黏膜切除术治疗大型无蒂锯齿状病变的回顾性比较

Piecemeal cold snare polypectomy versus conventional endoscopic mucosal resection for large sessile serrated lesions: a retrospective comparison across two successive periods.
PubMed 文献 · Gut · 2020-11-10

该回顾性研究比较了分块冷圈套息肉切除术(p-CSP)与传统内镜黏膜切除术(EMR)治疗大型(≥20 mm)无蒂锯齿状病变(L-SSL)的效果。p-CSP组156个病变,EMR组406个病变,技术成功率相当(100.0% vs 99.0%),p-CSP无不良事件,EMR组延迟出血和深部黏膜损伤发生率分别为5.1%和3.4%,复发率相似。结论认为p-CSP可考虑作为L-SSL治疗的新标准。

要点

  • p-CSP治疗L-SSL技术成功率与EMR相当(100.0% vs 99.0%)。
  • p-CSP无不良事件,EMR组延迟出血5.1%、深部黏膜损伤3.4%。
  • 两组复发率在首次和第二次监测结肠镜检查时均相似。

核心结论

  • p-CSP在技术成功率上与EMR相当,但几乎消除了延迟出血和穿孔的风险。
  • p-CSP应被视为L-SSL治疗的新标准。

研究设计与样本

  • 回顾性比较两个连续时期,在四个澳大利亚三级中心进行。
  • p-CSP组:2016年4月至2020年1月,156个L-SSL(121例患者);EMR组:2008年7月至2016年3月,406个L-SSL(353例患者)。
  • 监测结肠镜检查在6个月(SC1)和18个月(SC2)进行。

主要发现

  • 技术成功:p-CSP组100.0%(n=156),EMR组99.0%(n=402)。
  • p-CSP组无不良事件;EMR组延迟出血5.1%(n=18),深部黏膜损伤3.4%(n=12)。
  • 复发率:SC1时p-CSP组4.3%(n=4) vs EMR组4.6%(n=14);SC2时p-CSP组2.0%(n=1) vs EMR组1.2%(n=3)。

临床怎么用

  • 对于大型(≥20 mm)无蒂锯齿状病变,可优先考虑分块冷圈套息肉切除术。
  • p-CSP可降低延迟出血和深部黏膜损伤风险,且复发率与EMR相似。

局限性

  • 回顾性比较,非随机分组,存在时间偏倚。
  • 样本来自四个澳大利亚三级中心,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Large (≥20 mm) sessile serrated lesions (L-SSL) are premalignant lesions that require endoscopic removal. Endoscopic mucosal resection (EMR) is the existing standard of care but carries some risk of adverse events including clinically significant post-EMR bleeding and deep mural injury (DMI). The respective risk-effectiveness ratio of piecemeal cold snare polypectomy (p-CSP) in L-SSL management is not fully known. DESIGN: Consecutive patients referred for L-SSL management were treated by p-CSP from April 2016 to January 2020 or by conventional EMR in the preceding period between July 2008 and March 2016 at four Australian tertiary centres. Surveillance colonoscopies were conducted at 6 months (SC1) and 18 months (SC2). Outcomes on technical success, adverse events and recurrence were documented prospectively and then compared retrospectively between the subsequent time periods. RESULTS: A total of 562 L-SSL in 474 patients were evaluated of which 156 L-SSL in 121 patients were treated by p-CSP and 406 L-SSL in 353 patients by EMR. Technical success was equal in both periods (100.0% (n=156) vs 99.0% (n=402)). No adverse events occurred in p-CSP, whereas delayed bleeding and DMI were encountered in 5.1% (n=18) and 3.4% (n=12) of L-SSL treated by EMR, respectively. Recurrence rates following p-CSP were similar to EMR at 4.3% (n=4) versus 4.6% (n=14) and 2.0% (n=1) versus 1.2% (n=3) for surveillance colonoscopy (SC)1 and SC2, respectively. CONCLUSIONS: In a historical comparison on the endoscopic management of L-SSL, p-CSP is technically equally efficacious to EMR but virtually eliminates the risk of delayed bleeding and perforation. p-CSP should therefore be considered as the new standard of care for L-SSL treatment.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. van Hattem WA, Shahidi N, Vosko S, et al. Piecemeal cold snare polypectomy versus conventional endoscopic mucosal resection for large sessile serrated lesions: a retrospective comparison across two successive periods. Gut. 2020. PMID: 33172927. doi:10.1136/gutjnl-2020-321753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。